A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Powered by MRP Announces Exclusive Agreement with LUVO Medical

To Distribute Aesthetic Devices in the United States

MRP.io (“MRP”) announced today that it has signed an exclusive agreement with LUVO Medical, headquartered in Ontario, Canada, for the sale and distribution of four LUVO products in the United States – the Bare 808, Bela MD+ Advanced Skin Health Platform, the Darwin and the Lucent IPL.

MRP founder and CEO Scott Carson stated, “This partnership is an amazing opportunity for Powered by MRP to get LUVO Medical products into the hands of clinicians in the United States for the first time.”

Modifying the aesthetics marketplace through successful sales and guarantees of pre-owned equipment, MRP has continued to expand its catalog of new equipment sales and distribution from manufacturers, including its latest venture with LUVO Medical.

“We are thrilled to partner with MRP for the exclusive sale of four LUVO devices in the United States,” said Kevin Noseworthy, VP of Sales at LUVO medical. “With the Bela MD+ Advanced Skin Health Platform being one of the most sought-after products for 2022, this couldn’t have come at a better time for LUVO Medical and MRP.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy